SCHEMBL8675935

SCHEMBL8675935

COc1ccc(S(=O)(=O)[C@@H]2CC(C)CC[C@@]2(O)NCC(=O)OCc2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP9 P14780 7/20 0.41
▸ MMP1 P03956 7/20 0.41
▸ MMP3 P08254 5/20 0.41
▸ MMP2 P08253 5/20 0.41
▸ MMP7 P09237 2/20 0.41
▸ MMP8 P22894 1/20 0.41
▸ MMP13 P45452 5/20 0.40
▸ KCNA5 P22460 1/20 0.39
▸ HTT P42858 2/20 0.38
▸ PKM P14618 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ ADAM17 P78536 2/20 0.37
▸ CHRM2 P08172 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8671394 0.74 MMP1 (0.45) MMP9MMP1MMP3MMP2MMP7
SCHEMBL7350978 0.68 KCNA5 (0.54) MMP9MMP1MMP3MMP2MMP13
SCHEMBL8477947 0.67 KCNA5 (0.45) MMP9MMP1MMP2MMP13KCNA5
SCHEMBL7419400 0.67 KCNA5 (0.48) MMP9MMP1MMP3MMP2MMP7
SCHEMBL11453114 0.66 ALDH1A1 (0.56) SMN1; SMN2CA1CA2ACHECYP1A2
SCHEMBL7351711 0.65 KCNA5 (0.53) MMP9MMP1MMP2MMP13KCNA5
SCHEMBL209395 0.65 KMT2A (0.59) HTTSMN1; SMN2CYP1A2CYP3A4CYP2D6
SCHEMBL8675938 0.64 KEAP1 (0.46) MMP9MMP1MMP3MMP2MMP7
SCHEMBL7421563 0.64 KEAP1 (0.48) MMP9MMP1MMP2MMP13KCNA5
SCHEMBL26381709 0.64 PKM (0.53) MMP9MMP1MMP3MMP2MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5770624-A INHIBITORS OF TUMOR NECROSIS FACTOR ALPHA AND MATRIX DEGRADING METALLOPROTEINEASE ACTIVITY NOVARTIS CORP. (US) 1998-06-23 — — US disclosed
Send feedback